Melflufen
OP-103
Phase 3 small_molecule terminated
Quick answer
Melflufen for Multiple Myeloma is a Phase 3 program (small_molecule) at Oncopeptides AB (publ) with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oncopeptides AB (publ)
- Indication
- Multiple Myeloma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated